Oral peptide GLP-1 receptor agonist

Semaglutide 40 mg tablet once daily

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

SEMA_PO_40MG_QD

Mechanism: Oral semaglutide with absorption enhancer
Trials: 0
Participants in these arms: 0

All doses pooled: Semaglutide tablet
Semaglutide 14 mg oral once daily (original tablet)
Semaglutide 20 mg tablet once daily
Semaglutide 3 mg oral once daily (original tablet)
Semaglutide 7 mg oral once daily (original tablet)
Semaglutide oral once daily (original tablet), flexible dose: 3, 7 or 14 mg adjusted by HbA1c and tolerability
Semaglutide 50 mg oral once daily (higher dose oral program)

Semaglutide 40 mg tablet once daily

Related

Trials